TherapeuticsMD (TXMD)
NASDAQ:TXMD

TherapeuticsMD (TXMD) Stock Forecast & Price Target

2,222 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Currently, no data available
Based on 0 analysts giving stock ratings to
TherapeuticsMD
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TXMD Stock Price Prediction

There Are No Analyst Ratings for TXMD In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Cantor Fitzgerald
$1.00
Hold
-77.58%
Downside
Initiated
Cantor Fitzgerald Reiterates Neutral on TherapeuticsMD, Announces $1 Price Target
H.C. Wainwright
$10.00
Hold
124.22%
Upside
Downgraded
Analysts' Opinions Are Mixed on These Healthcare Stocks: TherapeuticsMD (NASDAQ: TXMD), Checkpoint Therapeutics (NASDAQ: CKPT) and Adicet Bio (NASDAQ: ACET)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

TXMD Financial Forecast

TXMD Earnings Forecast
Next quarter’s earnings estimate for TXMD is ― with a range of ― to ―. The previous quarter’s EPS was -$3.13. TXMD beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.52% of the time in the same period. In the last calendar year TXMD has Underperformed its overall industry.
Next quarter’s earnings estimate for TXMD is ― with a range of ― to ―. The previous quarter’s EPS was -$3.13. TXMD beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.52% of the time in the same period. In the last calendar year TXMD has Underperformed its overall industry.
TXMD Sales Forecast
Next quarter’s sales forecast for TXMD is ― with a range of ― to ―. The previous quarter’s sales results were $20.92M. TXMD beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 42.90% of the time in the same period. In the last calendar year TXMD has Outperformed its overall industry.
Next quarter’s sales forecast for TXMD is ― with a range of ― to ―. The previous quarter’s sales results were $20.92M. TXMD beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 42.90% of the time in the same period. In the last calendar year TXMD has Outperformed its overall industry.
TXMD Analyst Recommendation Trends
In the current month, TXMD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TXMD average analyst price target in the past 3 months is ―
In the current month, TXMD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TXMD average analyst price target in the past 3 months is ―

TXMD Stock Forecast FAQ

What is TXMD’s average 12-month price target, according to analysts?
Currently, no data Available
What is TXMD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TXMD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is TXMD a Buy, Sell or Hold?
      Currently, no data Available
      What is TherapeuticsMD’s price target?
      Currently, no data Available
      What do analysts say about TherapeuticsMD?
      Not enough analysts have published a price target to provide an average price target.

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis